Skip to main content
. 2019 Aug 16;98(33):e16785. doi: 10.1097/MD.0000000000016785

Table 4.

Logistic regression model adjusted to sex and age group for adverse events induced by aflibercept and ranibizumab from July 2007 to December 2016 in South Korea.

3.